Randomized controlled trial comparing deep dermal glanular hyaluronic acid injection versus oral dapoxetine in management of premature ejaculation
International Urology and Nephrology · 20.07.2026 · 58 (12) · 5291-5299
DOI: 10.1007/s11255-026-05274-2 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Urology and Nephrology, online erschienen am 20.07.2026. Verfasst von Hesham Torad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Urology Department, Kasr Alainy Hospitals, Faculty of Medicine, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Hyaluronic Acid, Naphthalenes, Benzylamines, Premature Ejaculation. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
Premature ejaculation (PE) is a common male sexual dysfunction with significant psychosocial consequences. Available treatment options include behavioral therapy, topical agents, and pharmacological interventions. This randomized controlled trial aims to compare the efficacy and safety of deep dermal glanular hyaluronic acid (HA) injection versus oral dapoxetine in men with lifelong PE refractory to behavioral therapy.
Results
Sixty men aged ≥ 18 years were randomly assigned to receive either oral dapoxetine 60 mg three times weekly (Group A) or HA injection into the glans penis (Group B). The primary endpoint was the change in intravaginal ejaculation latency time (IELT) at 6 months following treatment initiation, while secondary outcomes included International Index of Erectile Function-5 (IIEF-5), Index of Premature Ejaculation (IPE), quality of life (QoL), patient satisfaction, and adverse events. Assessments were conducted at baseline and at 1, 3, and 6 months. Both groups demonstrated significant improvements in IELT, IIEF-5, IPE, and QoL at all follow-up time points compared with baseline ( p < 0.05). However, improvements were significantly greater in the HA group at 1, 3, and 6 months ( p < 0.05). Patient satisfaction was consistently higher in the HA group throughout follow-up ( p < 0.05). Adverse events in the dapoxetine group included nausea, dizziness, headache, and dry mouth, whereas the HA group experienced transient injection-site pain, ecchymosis, and bullae formation.
Conclusion
Deep dermal glanular hyaluronic acid injection is more effective than oral dapoxetine in improving ejaculatory control, sexual function, and quality of life in men with lifelong PE, with an acceptable safety profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Urology Department, Kasr Alainy Hospitals, Faculty of Medicine, Cairo University, Cairo, Egypt.
- Urology Department, Kasr Alainy Hospitals, Faculty of Medicine, Cairo University, Cairo, Egypt. ahmedrammah2013@gmail.com.
- Department of Andrology, Faculty of Medicine, Cairo University, Cairo, Egypt.
- Department of Urology, Faculty of Medicine, Menoufia University, Shebeen El-Kom, Menoufia, Egypt.
- Department of Urology, Rhein-Maas Hospital, Würselen, Germany.
- Department of Urology, Faculty of Medicine, Benha University, Benha, Egypt.
ORCID-Profile: Ahmed M Rammah
Zitieren
APA
Torad, H., Rammah, A. M., Elahwany, A., Ahmed, K. S., Noureldin, Y. A., & Abdelrasol, W. F. (2026). Randomized controlled trial comparing deep dermal glanular hyaluronic acid injection versus oral dapoxetine in management of premature ejaculation. International Urology and Nephrology, 58(12), 5291-5299. https://doi.org/10.1007/s11255-026-05274-2
Vancouver
Torad H, Rammah AM, Elahwany A, Ahmed KS, Noureldin YA, Abdelrasol WF. Randomized controlled trial comparing deep dermal glanular hyaluronic acid injection versus oral dapoxetine in management of premature ejaculation. International Urology and Nephrology. 2026;58(12):5291-5299. doi:10.1007/s11255-026-05274-2
BibTeX
@article{Torad2026,
author = {Torad, Hesham and Rammah, Ahmed M and Elahwany, Amr and Ahmed, Khalid Sayed and Noureldin, Yasser A and Abdelrasol, Waheed F},
title = {Randomized controlled trial comparing deep dermal glanular hyaluronic acid injection versus oral dapoxetine in management of premature ejaculation},
journal = {International Urology and Nephrology},
year = {2026},
volume = {58},
number = {12},
pages = {5291--5299},
doi = {10.1007/s11255-026-05274-2}
}
EUVIMED